Bicalutamide is named as a drug or biological intervention in 3 clinical trials in our USA, China and UK trial registers, 1 of which is recruiting. Lead sponsors include Aragon Pharmaceuticals, Inc. (1), Alessa Therapeutics Inc. (1) and Peking Union Medical College (1). Registered phases: Phase 3, Phase 1 and Phase 2. Conditions studied include Prostatic Neoplasms; Prostate Adenocarcinoma; Salivary Gland Carcinoma.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT06145308 | Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing (ClinicalTrials.gov ↗) Salivary Gland Carcinoma, Precision Therapy |
Phase 2 | Recruiting |
| NCT02531516 | An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS (ClinicalTrials.gov ↗) Prostatic Neoplasms |
Phase 3 | Active, closed |
| NCT04943536 | Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate Cancer (ClinicalTrials.gov ↗) Prostate Adenocarcinoma |
Phase 1 | Active, closed |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Prostatic Neoplasms | 1 |
| Prostate Adenocarcinoma | 1 |
| Salivary Gland Carcinoma | 1 |
| Precision Therapy | 1 |
| Lead sponsor | Trials |
|---|---|
| Aragon Pharmaceuticals, Inc. | 1 |
| Alessa Therapeutics Inc. | 1 |
| Peking Union Medical College | 1 |
| Register | Bicalutamide trials |
|---|---|
| Clinical trials in USA | 2 |
| Clinical trials in China | 2 |
| Clinical trials in UK | 1 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Bicalutamide works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Bicalutamide (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.